Active	Status	Sponsor type	Region	Phase	Filter
5 Active 1 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Offidani, Massimo
KRdvsRd, NCT04096066: A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant	Active, not recruiting	3	84	Europe	Carfilzomib, Kyprolis, Lenalidomide, Revlimid, Dexamethasone	Fondazione EMN Italy Onlus	Multiple Myeloma, New Diagnosis Tumor	01/26	01/26
iinnovate-1, NCT03215030 / 2021-006038-37: A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma	Completed	1/2	272	Europe, Canada, Japan, US, RoW	Modakafusp alfa, TAK-573, TEV-48573, Dexamethasone	Takeda, Takeda Development Center Americas, Inc.	Multiple Myeloma	07/24	11/24
MY MYELOMA, NCT05001087: A "Physician & Patient-powered" Cohort Registry	Recruiting	N/A	1900	Europe	Observation	Fondazione EMN Italy Onlus	Multiple Myeloma	03/24	03/24
NCT05393024: Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy	Completed	N/A	78	Europe	Belantamab mafodotin	Fondazione EMN Italy Onlus	Multiple Myeloma	08/24	08/24
CLARITY, NCT03190525: Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma	Recruiting	N/A	520	Europe	Quality of life questionnaires	Gruppo Italiano Malattie EMatologiche dell'Adulto	Multiple Myeloma	12/24	12/24